|Table of Contents|

Radiofrequency ablation for metastatic tumor after pneumonectomy：Clinical evaluation of 5 cases

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 10
Page:
1843-1848
Research Field:
Publishing date:

Info

Title:
Radiofrequency ablation for metastatic tumor after pneumonectomy：Clinical evaluation of 5 cases
Author(s):
TAN Xiaogang; WANG Hong; LIU Lei; LIU Baodong
Department of Thoracic Surgery，Xuanwu Hospital，Capital Medical University，Beijing 100053，China.
Keywords:
radiofrequency ablation; pneumonectomy; single lung; feasibility; safety
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2023.10.013
Abstract:
Objective:To retrospectively evaluate the feasibility,effectiveness and safety of CT guided percutaneous radiofrequency ablation (RFA) in the treatment of metastatic tumor after pneumonectomy.Methods:From January 2010 to May 2022,5 patients with single lung metastasis tumors (5 males,mean age 59.6 years old) underwent 8 times of RFA.4 patients had postoperative metastasis of primary lung cancer and 1 patient had lung metastasis of renal pelvis and ureter tumor.One patient underwent two RFAs due to local recurrence of the tumor.Another patient underwent three RFAs due to local recurrence of the tumor.The mean tumor size was 3.0 cm (range from 2.0 to 5.0 cm).According to the CT examination immediately after RFA and clinical follow-up results,the feasibility,effectiveness and safety of RFA in the treatment of metastatic tumors after pneumonectomy were evaluated.Results:Complications after RFA included pneumothorax (37.5%),chest pain (37.5%) and post-ablation syndrome (25.0%) with low fever as the main manifestation.None of the patients died during the procedure or in the 30 days after RFA.The survival periods of dead cases were 3 months,25 months and 33 months,respectively.One case survived for 38 months after the first RFA and the other case survived for 3 months.Conclusion:RFA can offer local tumor control after pneumonectomy and can be conducted repeatly after pneumonectomy.RFA is safe,feasible and effective for the treatment of metastatic tumors after pneumonectomy.

References:

[1]SIEGEL RL,MILLER KD,FUCHS HE,et al.Cancer statistics,2022［J］.CA:Cancer J Clin,2022,72(1):7-33.
[2]FANG WT,CHEN TB,LUO JZ,et al.Minimally invasive surgery for centrally located lung cancers［J］.Chin J Surg,2020,58(1):57-60.
[3]STEWART CL,WARNER S,ITO K,et al.Cytoreduction for colorectal metastases:liver,lung,peritoneum,lymph nodes,bone,brain.When does it palliate,prolong survival,and potentially cure［J］.Curr Probl Surg,2018,55(9):330-379.
[4]FOSTER CC,RUSTHOVEN CG,SHER DJ,et al.Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall:A National Cancer Database Analysis［J］.Lung Cancer,2019,130(4):162-168.
[5]PAEZ-CARPIO A,GOMEZ FM,ISUS OLIVE G,et al.Image-guided percutaneous ablation for the treatment of lung malignancies:current state of the art［J］.Insights Imaging,2021,12(1):57.
[6]LASSANDRO G,PICCHI SG,BIANCO A,et al.Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC:a five years study［J］.Med Oncol,2020,37(4):25.
[7]LENCIONI R,CROCETTI L,CIONI R,et al.Response to radiofrequency ablation of pulmonary tumours:a prospective,intentionto-treat,multicentre clinical trial(the RAPTURE study)［J］.Lancet Oncol,2008,9(7):621-628.
[8]HUANG BY,LI XM,SONG XY,et al.Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer:A retrospective cohort study［J］.Int J Surg,2018,53(5):143-150.
[9]LIU BD,YE X,FAN WJ,et al.Expert consensus on image-guided radiofrequency ablation of pulmonary tumors:2018 edition［J］.Thorac Cancer,2018,9(9):1194-1208.
[10]AMBROGI MC,FANUCCI O,LENCIONI R,et al.Pulmonary radiofrequency ablation in a single lung patient［J］.Thorax,2006,61(9):828-829.
[11]MODESTO A,GIRON J,MASSABEAU C,et al.Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient:case report and review of the literature［J］.Lung Cancer,2013,80(3):341-343.
[12]SONG Q,LI G,CHEN F,et al.Radiofrequency ablation for lung squamous cell carcinoma in a single-lung patient:A case report and literature review［J］.Medicine,2019,98(23):e15805.
[13]WEI Z,WANG J,YE X,et al.Computed tomography-guided percutaneous microwave ablation of early stage non-small cell lung cancer in a pneumonectomy patient［J］.Thorac Cancer,2016,7(1):151-153.
[14]HESS A,PALUSSIERE J,GOYERS JF,et al.Pulmonary radiofrequency ablation in patients with a single lung:feasibility,effificacy and tolerance［J］.Radiology,2011,258(2):635-642.
[15]SOFOCLEOUS CT,MAY B,PETRE EN,et al.Pulmonary thermal ablation in patients with prior pneumonectomy［J］.Am J Roentgenol,2011,196(5):606-612.
[16]YANG X,YE X,ZHANG L,et al.Microwave ablation for lung cancer patients with a single lung:Clinical evaluation of 11 cases［J］.Thorac Cancer,2018,9(5):548-554.
[17]谭晓刚,刘宝东.射频消融治疗肺磨玻璃结节的临床价值［J］.中国肺癌杂志,2021,24(10):677-682. TAN XG,LIU BD.Clinical value of radiofrequency ablation in the treatment of pulmonary ground glass nodules［J］.Chinese Journal of Lung Cancer,2021,24(10):677-682.
[18]YE X,FAN WJ,CHEN JH,et al.Chinese expert consensus workshop report:Guidelines for thermal ablation of primary and metastatic lung tumors［J］.Thorac Cancer,2015,6(1):112-121.
[19]AHMED M,SOLBIATI L,BRACE CL,et al.Image-guided tumor ablation:Standardization of terminology and reporting criteria-a 10 year update［J］.Radiology,2014,273(1):241-260.
[20]DONINGTON JS,MILLER DL,ROWLAND CC,et al.Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy［J］.Ann Thorac Surg,2002,74(1):154-158.
[21]JONES GD,TAN KS,CASO R,et al.Time-varying analysis of readmission and mortality during the first year after pneumonectomy［J］.J Thorac Cardiovasc Surg,2020,160(1):247-255.
[22]LIGNIERES M,ROUX N,GIORGI R,et al.Persistent pathways after lung radiofrequency ablation as a risk factor of drain placement［J］.Int J Hyperthermia,2017,33(6):659-663.
[23]DASSA M,IZAARYENE J,DAIDJ N,et al.Efficacy of tract embolization after percutaneous pulmonary radiofrequency ablation［J］.Cardiovasc Intervent Radiol,2021,44(6):903-910.
[24]YASUDA M,NAKANISHI R,MORI M,et al.Simple covering technique in thoracoscopic bullectomy for spontaneous pneumothorax［J］.J Thorac Dis,2017,9(11):4584-4588.
[25]KWAN SW,MORTELI KE，TALENFELD AD,et al.Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer［J］.J Vase Interv Radiol,2014,25(1):1-9．
[26]刘宝东,胡牧,刘磊,等.射频消融联合表皮生长因子受 体酪氨酸激酶抑制剂治疗表皮生长因子受体突变非小细胞肺癌的临床价值［J］.介入放射学杂志,2018,27(11):1036-1039. LIU BD,HU M,LIU L,et al.Radiofrequency ablation combined with EGFR-TKIs for EGFR mutant non-small cell lung cancer:its clinical application［J］.Journal of Interventional Radiology,2018,27(11):1036-1039.
[27] MAXWELL AW HEALEY TT,DUPU DE.Percutaneous thermal ablation for small-cell lung cancer:initial experience with ten tumors in nine patients［J］.J Vasc Interv Radiol,2016,27(12):1815-1821.
[28]郑爱民.肺部肿瘤微波消融的严重并发症、疗效及其影响因素研究［D］.山东:山东大学,2015:45-55. ZHENG AM.Major complications,efficacy and their influential factors after microwave ablation for lung tumors:a retrospective pilot［D］.Shandong：Shandong University,2015:45-55.
[29]YANG WY,HE Y,HU Q,et al.Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer:A propensity-matched analysis［J］.Front Oncol,2022,12:984932.
[30]YAN D,KING J,SJARIF A,et al.Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma:a prospective study of 70 consecutive cases［J］.Annals of Surgical Oncology,2006,13(12):1588-1595.

Memo

Memo:
首都医科大学临床专科学院（系）开放课题（编号：RG00667）
Last Update: 1900-01-01